Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon May 26, 2022 12:28pm
158 Views
Post# 34709445

RE:RE:RE:RE:RE:RE:Matthew Pietras

RE:RE:RE:RE:RE:RE:Matthew Pietraswhy would they send him packing and not Tripp or anyone else ever before?

Look at all the late reportings of the past.  The botched news releases.  The changing of auditors, accounting issues they always have for such a tiny company.

What actually killed the SP of this company was that they waited until the last possible second like they always do to release that BS Care news rather than release news that "Arisototle is officially released"

Instead the bone heads that were there before Matt released CARE news out of no where and didnt mention aristotle at all. Even during that disaster of a conference call its like they didnt even want to talk about Aristotle.  They were so proud of themselves with where the SP was thanks to covid and their dumb luck they thought anyone would eat up their CARE idea.

Tripp made a mistake that has crushed this company and yet he gets off scot free and Matt gets fired?  Is that your excuse?

Imagine April 1 2021 Stagezero NR announcing the official release of Aristotle.  Then 3 days later releasing an NR teaming up with CARE oncology just stating a possible of joining together or purchase option if certain criteria is met and if it makes sense.  In the short term this stock would had blasted over 2 bucks and maybe even approached $2.50

Instead thanks to Tripp and others before Matt was even an employee the stock has lost 98% of its value.  

Yeah get rid of Matt, that guy really screwed the investors.  Give me a break.
<< Previous
Bullboard Posts
Next >>